temocillin has been researched along with E coli Infections in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (31.58) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Bredelyte-Gruodiene, E; Ciapiene, I; Giedraitiene, A; Pereckaite, L; Tatarunas, V; Virgailis, M | 1 |
| Eslami, P; Mardani, M; Rahbar, M; Van de Velde, S | 1 |
| Chenouard, R; Dubée, V; Eveillard, M; Luque Paz, D; Mahieu, R; Marion, E | 1 |
| Körber-Irrgang, B; Kresken, M; Pfeifer, Y; Werner, G | 1 |
| Berleur, M; Cattoir, V; Chau, F; de Lastours, V; Fantin, B; Guérin, F; Massias, L; Poujade, J | 1 |
| Cattoen, C; Duployez, C; Loïez, C; Vachée, A; Wallet, F | 1 |
| Cavaco, LM; Hammerum, AM; Hansen, F; Hasman, H; Hendriksen, RS; Hill, RLR; Le Hello, S; Mushtaq, S; Woodford, N | 1 |
| Alexandre, K; Caron, F; Chau, F; Etienne, M; Fantin, B; Soares, A | 1 |
| Cheong, HJ; Cho, YK; Choi, TY; Chung, MH; Kang, JO; Ki, M; Kim, J; Kim, SJ; Kim, Y; Kwon, KT; Lee, H; Lee, JS; Lim, SK; Pai, H; Park, DW; Ryu, SY; Seo, MR; Wie, SH | 1 |
| Chau, F; Couffignal, C; Fantin, B; Lepeule, R; Massias, L; Mentre, F; Rossi, B; Ruppé, E; Soubirou, JF | 1 |
| Alexandre, K; Cattoir, V; Chau, F; Fantin, B; Guérin, F; Lefort, A; Massias, L | 1 |
| Ahmad Murad, K; Chen, YT; Ng, LS; Park, JJ; Seah, JT; Tan, TY | 1 |
| de Mendonça, R; Frankard, J; Malaviolle, V; Nonhoff, C; Rodriguez-Villalobos, H; Struelens, MJ | 1 |
| Asbach, HW; Becker-Boost, E; Melekos, MD | 1 |
| Bauernfeind, A; Gutschow, K; Luehr, HG; Weissenbacher, ER | 1 |
| Boelaert, J; Lambert, A; Van Couter, A; Van Landuyt, HW | 1 |
| Beattie, AD; Lindsay, G; Taylor, EW | 1 |
| Fock, RR; Pfeiffer, M | 1 |
| Amstutz, P; Hericord, P; Leaute, JB; Lesage, D; Offenstadt, G; Pinta, P | 1 |
19 other study(ies) available for temocillin and E coli Infections
| Article | Year |
|---|---|
CTX-M-producing
Topics: Anti-Bacterial Agents; beta-Lactamases; Biofilms; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Penicillins | 2022 |
Activity of temocillin and comparators against urinary Escherichia coli and Klebsiella pneumoniae from Iran.
Topics: Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Female; Humans; Iran; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Urinary Tract Infections | 2020 |
Impact of ceftriaxone and temocillin on fecal abundance of extended-spectrum β-lactamase producing Escherichia coli in a mouse model.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Disease Models, Animal; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Male; Mice; Microbial Sensitivity Tests; Penicillins | 2021 |
Activity of temocillin against CTX-M-producing Escherichia coli and Klebsiella pneumoniae from Germany.
Topics: Anti-Bacterial Agents; beta-Lactamases; Dose-Response Relationship, Drug; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Germany; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillins | 2018 |
Activity of fosfomycin alone or combined with temocillin in vitro and in a murine model of peritonitis due to KPC-3- or OXA-48-producing Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Bacterial Proteins; beta-Lactamases; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fosfomycin; Mice; Microbial Sensitivity Tests; Penicillins; Peritonitis | 2018 |
In vitro activity of temocillin against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urinary tract infections in France.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; France; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillins; Urinary Tract Infections | 2019 |
Evaluation of temocillin for phenotypic carbapenemase screening of Escherichia coli and Salmonella enterica isolates in relation to the presence of genes encoding ESBLs and carbapenemase production.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Culture Media; Escherichia coli; Escherichia coli Infections; Genotype; Mass Screening; Penicillins; Salmonella enterica; Salmonella Infections | 2019 |
Temocillin breakpoints in pyelonephritis: evaluation in a murine model due to ESBL-producing Escherichia coli clinical isolates.
Topics: Administration, Intravenous; Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; Colony Count, Microbial; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Humans; Kidney; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Penicillins; Pyelonephritis | 2019 |
Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea.
Topics: Anti-Bacterial Agents; Cefepime; Cell Survival; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Nitrofurantoin; Penicillins; Republic of Korea; Sulfadoxine; Treatment Outcome; Trimethoprim; Urinary Tract Infections | 2014 |
Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Imipenem; Mice, Inbred CBA; Microbial Sensitivity Tests; Penicillins; Treatment Outcome; Urinary Tract Infections | 2015 |
Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteremia; Bacterial Proteins; beta-Lactamases; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Injections, Subcutaneous; Intraabdominal Infections; Mice; Microbial Sensitivity Tests; Penicillins; Plasma; Spleen; Survival Analysis; Treatment Outcome | 2016 |
In Vitro Efficacy of Six Alternative Antibiotics against Multidrug Resistant Escherichia Coli and Klebsiella Pneumoniae from Urinary Tract Infections.
Topics: Amdinocillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefpodoxime; Ceftibuten; Ceftizoxime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Genotype; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Penicillins; Singapore; Trimethoprim; Urinary Tract Infections | 2016 |
In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
Topics: Anti-Bacterial Agents; Belgium; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals, University; Humans; Microbial Sensitivity Tests; Penicillins | 2006 |
Clinical evaluation of temocillin in urinary tract infections.
Topics: Adult; Aged; Cystitis; Escherichia coli Infections; Female; Humans; Kidney Tubules; Male; Middle Aged; Penicillins; Pseudomonas Infections; Pyelonephritis; Urinary Tract Infections | 1985 |
Temocillin treatment of gynaecological infections with special reference to blood and tissue concentrations.
Topics: Adult; Aged; Escherichia coli Infections; Female; Genital Diseases, Female; Genitalia, Female; Humans; Kinetics; Middle Aged; Penicillins; Pseudomonas Infections; Staphylococcal Infections; Tissue Distribution; Urinary Tract Infections | 1985 |
Temocillin in the treatment of gram-negative septicaemia.
Topics: Aged; Escherichia coli Infections; Gram-Negative Bacteria; Humans; Klebsiella Infections; Klebsiella pneumoniae; Penicillins; Sepsis | 1985 |
Temocillin in the treatment of serious gram-negative infections.
Topics: Adult; Aged; Bacterial Infections; Drug Tolerance; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Gram-Negative Bacteria; Humans; Klebsiella Infections; Male; Middle Aged; Penicillins; Proteus Infections; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1985 |
Therapeutic experience with temocillin in peritonitis.
Topics: Adult; Aged; Drug Tolerance; Escherichia coli Infections; Humans; Middle Aged; Penicillins; Peritonitis; Pneumonia; Proteus Infections | 1985 |
Temocillin treatment of serious infections due to gram-negative bacilli in an intensive care unit.
Topics: Adult; Aged; Bacterial Infections; Biliary Tract Diseases; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Gram-Negative Bacteria; Humans; Intensive Care Units; Male; Middle Aged; Penicillin Resistance; Penicillins; Pneumonia; Proteus Infections; Sepsis; Urinary Tract Infections | 1985 |